An informative live chat to learn about a currently enrolling clinical trial for those diagnosed with Familial Adenomatous Polyposis.

You’re invited to attend an informational discussion on clinical research and familial adenomatous polyposis (FAP). The event will be hosted by Cancer Prevention Pharmaceuticals (CPP) with guest speakers from the Hereditary Colon Cancer Foundation and the Cleveland Clinic.

Guest Speakers: 
•Travis Bray, PhD – Hereditary Colon Cancer Foundation 
•Carol Burke, MD – Cleveland Clinic

Facilitated by: 
•Barbara Lambeth, RN, CCRC – Cancer Prevention Pharmaceuticals, Inc.

There will be a Q&A session at the end of the Live Chat and you are encouraged to ask questions, although, not required.

Space is limited, so please RSVP by filling out the registration page using only your first name and last initial. Please be sure to use a VALID email address, as a confirmation email including “join-in” instructions will be sent to this address on the day of the event.

We will not share your personal information with any third parties without your consent. The information collected is strictly for webinar related correspondence.

The Live Chat is open to anyone who wishes to attend. Patients, caregivers, family members and friends are all welcome to sign up. We look forward to seeing you on Wednesday, March 25, 2015!

About the Speakers 

Travis Bray, PhD, Previvor, Founder, and Executive Director, Hereditary Colon Cancer Foundation

Travis H. Bray is a third generation F.A.P. previvor and understands firsthand the long-reaching physical and emotional effects living with this disease has on both the patient and their loved ones. By drawing upon personal experiences with F.A.P., as well as those of his extended family, he is motivated to developing a patient advocacy organization for those born or affected by hereditary colon cancer. Travis graduated with top honors for his graduate work in Actinide Chemistry at Auburn University in 2008. He continued his research for two years as the Berkeley Actinide Postdoctoral Fellow at Lawrence Berkeley National Laboratory, and a third year of post-doctoral research at Argonne National Laboratory. Travis stepped away from his career as a chemistry researcher in 2012 to found the Hereditary Colon Cancer Foundation.

Carol Burke MD, Department of Gastroenterology and Hepatology, Cleveland Clinic

Carol Burke, MD, completed medical school at the Ohio State University College of Medicine and Public Health, and residency at Riverside Methodist Hospital, both in Columbus, Ohio. Dr. Burke performed her Gastroenterology Fellowship at the Cleveland Clinic in 1993 and has been on the professional staff since that time.

Dr. Burke enjoys patient care, medical education and research, particularly in the area of colorectal polyp and cancer prevention. She is internationally known for her work in the polyposis syndromes and is the Director of the Center for colon polyp and cancer prevention and has been awarded research grants from the National Cancer Institute, American College of Gastroenterology, and Industry to name a few, to study the effects of chemopreventive agents on the prevention of intestinal neoplasia.

She is the co-director of the multi-disciplinary Hereditary Cancer Clinic and provides consultations including risk assessment, and endoscopic evaluation and treatment for individuals with a hereditary predisposition to cancer.